Amino Acid Metabolism — MCQs

Q: Carbamoyl phosphate synthase I is involved in which of the following metabolic pathways?

Urea cycle. **Explanation:** **Carbamoyl Phosphate Synthetase I (CPS-I)** is the rate-limiting enzyme of the **Urea Cycle**. It catalyzes the condensation of ammonia ($NH_3$) and bicarbonate ($HCO_3^-$) to form carbamoyl phosphate. This reaction occurs exclusively in the **mitochondria** of hepatocytes and requires **N-acetylglutamate (NAG)** as an essential allosteric activator. **Analysis of Options:** * **A. Purine synthesis:** This pathway utilizes enzymes like PRPP synthetase and GPAT. Nitrogen is derived from glycine, aspartate, and glutamine, but CPS-I is not involved. * **B. Pyrimidine synthesis:** This pathway uses **Carbamoyl Phosphate Synthetase II (CPS-II)**. Unlike CPS-I, CPS-II is located in the **cytosol**, uses **glutamine** as the nitrogen donor, and is not activated by NAG. * **D. Uronic acid pathway:** This is an alternative pathway for glucose metabolism used for the synthesis of glucuronic acid, pentoses, and (in most animals) Vitamin C. It does not involve nitrogen metabolism or CPS enzymes. **High-Yield Clinical Pearls for NEET-PG:** * **CPS-I Deficiency:** The most severe urea cycle disorder, presenting with hyperammonemia, respiratory alkalosis, and neurological symptoms shortly after birth. Unlike OTC deficiency, there is **no orotic aciduria**. * **Mnemonic (CPS-I vs. II):** * **CPS-I:** **M**itochondria, **U**rea cycle (One = m**U**m). * **CPS-II:** **C**ytosol, **P**yrimidine synthesis (Two = **C**y**P**). * **N-acetylglutamate (NAG):** Produced from glutamate and acetyl-CoA; its synthesis is stimulated by Arginine. Without NAG, the Urea cycle cannot proceed.

Q: Blue diaper syndrome is associated with which of the following conditions?

Tryptophan malabsorption. **Explanation:** **Blue Diaper Syndrome** (Drummond’s Syndrome) is a rare, autosomal recessive metabolic disorder characterized by the **isolated malabsorption of Tryptophan** from the intestinal tract. **1. Why Option A is Correct:** In this condition, there is a defect in the transport system responsible for absorbing the amino acid Tryptophan. When Tryptophan remains unabsorbed in the gut, intestinal bacteria metabolize it into **Indole**. This indole is absorbed into the portal circulation and converted by the liver into **Indican** (Indoxyl sulfate). When Indican is excreted in the urine and exposed to air, it undergoes oxidation to form **Indigo Blue**, a water-insoluble pigment that stains the infant's diaper blue. **2. Why Other Options are Incorrect:** * **Option B:** Hyperabsorption of Tryptophan does not occur in this pathology; the issue is a transport deficiency leading to bacterial putrefaction. * **Options C & D:** Tyrosine metabolism defects are associated with conditions like Alkaptonuria (Black urine) or Tyrosinemia, but they do not produce the characteristic blue pigment associated with indole derivatives. **Clinical Pearls for NEET-PG:** * **Clinical Presentation:** Infants present with digestive disturbances, irritability, and visual defects (e.g., cataracts, microphthalmos). * **Hypercalcemia:** Blue Diaper Syndrome is frequently associated with **familial hypercalcemia** and nephrocalcinosis, though the exact mechanism linking tryptophan transport to calcium levels remains unclear. * **Differential Diagnosis:** Do not confuse this with **Hartnup Disease**, which also involves Tryptophan malabsorption but affects other neutral amino acids and presents with pellagra-like skin rashes and ataxia.

Q: What is the difference in molecular weight between Phenylalanine and Tyrosine?

16. **Explanation:** The difference in molecular weight between Phenylalanine and Tyrosine is **16**, which corresponds to the atomic weight of a single **Oxygen (O)** atom. **1. Why the Correct Answer is Right:** The structural relationship between these two aromatic amino acids is defined by a single hydroxylation reaction. **Phenylalanine** ($C_9H_{11}NO_2$) is converted into **Tyrosine** ($C_9H_{11}NO_3$) by the enzyme **Phenylalanine Hydroxylase (PAH)**. This reaction adds a hydroxyl group (-OH) to the para-position of the phenyl ring. Since Tyrosine is simply "hydroxylated phenylalanine," the net addition is one oxygen atom ($16 \text{ Da}$). While a hydrogen is replaced by -OH, the net gain in mass is $16$ ($17 \text{ for OH} - 1 \text{ for the displaced H}$). **2. Why Other Options are Wrong:** * **Option A (17):** This represents the weight of a hydroxyl group (-OH) alone, without accounting for the displacement of the hydrogen atom from the benzene ring. * **Option C (64) & D (32):** These values do not correspond to any standard functional group differences in basic amino acid metabolism and are distractors. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Essential vs. Non-essential:** Phenylalanine is an **essential** amino acid, while Tyrosine is **semi-essential** (it becomes essential if Phenylalanine is deficient or if PAH is defective). * **Phenylketonuria (PKU):** A deficiency in **Phenylalanine Hydroxylase** (or its cofactor **Tetrahydrobiopterin, $BH_4$**) leads to PKU. In these patients, Tyrosine becomes a strictly essential amino acid. * **Metabolic Fate:** Both are **glucogenic and ketogenic**. They are precursors to Catecholamines (Dopamine, Epinephrine, Norepinephrine), Thyroxine ($T_4$), and Melanin.

Q: Which of the following is an optically inactive amino acid?

Glycine. ### Explanation **Correct Option: C (Glycine)** The optical activity of an amino acid depends on the presence of a **chiral center** (asymmetric carbon atom). A carbon is considered chiral when it is bonded to four different chemical groups. * In all standard amino acids, the $\alpha$-carbon is attached to: 1) an amino group ($-NH_2$), 2) a carboxyl group ($-COOH$), 3) a hydrogen atom ($-H$), and 4) a variable side chain ($-R$ group). * **Glycine** is the simplest amino acid. Its side chain ($-R$ group) is a **hydrogen atom**. Consequently, the $\alpha$-carbon is bonded to two identical hydrogen atoms, making it **achiral** (symmetric). Therefore, Glycine is the only proteinogenic amino acid that is **optically inactive** and does not exist in D- or L- isomeric forms. **Why Other Options are Incorrect:** * **A. Threonine:** Contains two chiral centers (the $\alpha$-carbon and the $\beta$-carbon), making it optically active. * **B. Tyrosine:** An aromatic amino acid with a complex side chain, possessing a chiral $\alpha$-carbon. * **D. Serine:** Contains a hydroxymethyl side chain; its $\alpha$-carbon is attached to four different groups, making it optically active. **High-Yield NEET-PG Clinical Pearls:** 1. **Isoleucine and Threonine:** These are the only two amino acids that possess **two chiral centers**. 2. **L-Configuration:** All amino acids found in human proteins are of the **L-configuration**. 3. **Glycine Functions:** It is essential for the synthesis of **Heme, Purines, Creatine, and Glutathione**. 4. **Inhibitory Neurotransmitter:** Glycine acts as a major inhibitory neurotransmitter in the **spinal cord**. 5. **Proline:** Often called an "imino acid," it contains a secondary amino group and causes "kinks" in alpha-helices.

Q: Type I Tyrosinemia is caused by a deficiency in which enzyme?

Fumarylacetoacetate hydrolase. ### Explanation **Correct Option: B. Fumarylacetoacetate hydrolase** Type I Tyrosinemia (also known as Tyrosinosis or Hepatorenal Tyrosinemia) is the most severe disorder of tyrosine metabolism. It is caused by a deficiency of **Fumarylacetoacetate hydrolase (FAH)**, the final enzyme in the tyrosine catabolic pathway. This deficiency leads to the accumulation of fumarylacetoacetate, which is diverted into the formation of **succinylacetone**. Succinylacetone is a potent toxin that causes liver failure, renal tubular dysfunction (Fanconi syndrome), and inhibits heme synthesis. **Analysis of Incorrect Options:** * **A. Tyrosine transaminase:** Deficiency causes **Type II Tyrosinemia** (Richner-Hanhart syndrome), characterized by painful corneal erosions and hyperkeratotic plaques on the palms and soles. * **C. 4-Hydroxyphenylpyruvate hydroxylase:** Deficiency leads to **Type III Tyrosinemia**, a very rare condition presenting with neurological symptoms and intellectual disability, but without the liver/kidney involvement seen in Type I. * **D. Maleylacetoacetate isomerase:** Deficiency of this enzyme is theoretically possible but clinically rare; it precedes the FAH step in the catabolic pathway. **High-Yield Clinical Pearls for NEET-PG:** * **Pathognomonic Marker:** Presence of **succinylacetone** in urine is diagnostic for Type I Tyrosinemia. * **Clinical Presentation:** "Cabbage-like" odor, acute hepatic failure, and increased risk of **Hepatocellular Carcinoma (HCC)**. * **Treatment:** **Nitisinone (NTBC)** is the drug of choice. It inhibits 4-hydroxyphenylpyruvate dioxygenase, preventing the formation of toxic metabolites. * **Diet:** Restriction of Phenylalanine and Tyrosine is mandatory.

Q: Which of the following amino acids is NOT glucogenic?

Lysine. **Explanation:** Amino acids are classified based on their metabolic end-products into three categories: **Glucogenic** (converted into glucose precursors like pyruvate or TCA cycle intermediates), **Ketogenic** (converted into acetyl-CoA or acetoacetate), or **Both**. **Why Lysine is the Correct Answer:** Lysine, along with Leucine, belongs to the category of **purely ketogenic** amino acids. These two are the only amino acids that cannot be converted into glucose because their catabolism yields only acetyl-CoA or acetoacetate. Since the pyruvate dehydrogenase reaction is irreversible, acetyl-CoA cannot be converted back into pyruvate for gluconeogenesis. **Analysis of Incorrect Options:** * **Arginine:** It is a **glucogenic** amino acid. It is converted into $\alpha$-ketoglutarate via the urea cycle and glutamate, which then enters the TCA cycle to form glucose. * **Histidine:** It is a **glucogenic** amino acid. It is deaminated to urocanate and eventually converted to glutamate, entering the TCA cycle as $\alpha$-ketoglutarate. * **Glycine:** It is a **glucogenic** amino acid. It can be converted into serine and subsequently into pyruvate, a primary substrate for gluconeogenesis. **High-Yield NEET-PG Pearls:** * **Purely Ketogenic:** Lysine and Leucine (Mnemonic: The "L"s are purely ketogenic). * **Both Glucogenic & Ketogenic:** Phenylalanine, Tyrosine, Tryptophan, Isoleucine, and Threonine (Mnemonic: **PITTT**). * **Purely Glucogenic:** All other 13 amino acids. * **Clinical Correlation:** In states of starvation or uncontrolled diabetes, ketogenic amino acids contribute to the formation of ketone bodies, while glucogenic ones maintain blood glucose levels.

Q: Carbamoyl phosphate intermediates the synthesis of which of the following?

Urea and Pyrimidine. **Explanation:** Carbamoyl phosphate is a critical metabolic intermediate that serves as a precursor in two distinct biochemical pathways: the **Urea Cycle** and **Pyrimidine Synthesis**. 1. **Urea Synthesis (Mitochondria):** In the first step of the urea cycle, ammonia and bicarbonate are condensed to form **Carbamoyl Phosphate** by the enzyme **Carbamoyl Phosphate Synthetase I (CPS-I)**. This occurs in the liver mitochondria and is the rate-limiting step for nitrogen excretion. 2. **Pyrimidine Synthesis (Cytosol):** In the de novo synthesis of pyrimidines (leading to UTP, CTP, and TTP), glutamine and bicarbonate form **Carbamoyl Phosphate** via the enzyme **Carbamoyl Phosphate Synthetase II (CPS-II)**. This occurs in the cytosol of most nucleated cells. **Analysis of Incorrect Options:** * **C. Uric acid:** This is the end product of **Purine** catabolism (Adenine and Guanine), not pyrimidine synthesis. * **D. Ketone bodies:** These are synthesized from **Acetyl-CoA** during periods of starvation or untreated diabetes; carbamoyl phosphate is not involved. **High-Yield Clinical Pearls for NEET-PG:** * **CPS-I vs. CPS-II:** Remember the mnemonic: **"I"** is for **I**nside the mitochondria (Urea cycle); **"II"** is for **II** (two) the cytosol (Pyrimidine synthesis). * **Ornithine Transcarbamylase (OTC) Deficiency:** This is the most common urea cycle disorder. When OTC is deficient, mitochondrial carbamoyl phosphate accumulates and leaks into the cytosol, where it enters the pyrimidine pathway, leading to **Orotic Aciduria**. * **Activator:** CPS-I requires **N-acetylglutamate (NAG)** as an absolute allosteric activator.

Q: Branched-chain amino acids are used in which of the following conditions?

Isolated hepatic failure. **Explanation:** The correct answer is **Isolated hepatic failure**. **Underlying Concept:** In hepatic failure, the liver’s ability to metabolize aromatic amino acids (AAA: Phenylalanine, Tyrosine, Tryptophan) is severely impaired, leading to elevated plasma levels. Conversely, levels of **Branched-Chain Amino Acids (BCAA: Leucine, Isoleucine, Valine)** decrease because they are primarily metabolized in the skeletal muscle, which becomes hypermetabolic to compensate for the liver's energy deficit. The **Fischer Ratio** (BCAA to AAA ratio) drops significantly. High AAA levels compete with BCAA for transport across the blood-brain barrier via the LAT1 transporter. Excess AAA leads to the production of "false neurotransmitters" (like octopamine), contributing to **Hepatic Encephalopathy**. Supplementing with BCAA-rich formulas helps restore the Fischer ratio, reduces brain uptake of AAA, and provides an alternative energy source for muscles. **Why other options are incorrect:** * **Sepsis, SIRS, and MODS:** These are systemic hypermetabolic states characterized by massive protein catabolism and cytokine storms. While BCAA metabolism is altered, the primary nutritional goal is meeting high caloric/protein demands rather than correcting a specific amino acid imbalance. Clinical trials have not shown a definitive survival benefit for BCAA-specific formulas in these conditions compared to standard high-protein enteral nutrition. **High-Yield Clinical Pearls for NEET-PG:** * **BCAA mnemonic:** **LIV** (Leucine, Isoleucine, Valine). * **Metabolism:** Unlike most amino acids, BCAAs bypass the liver and are metabolized by **Branched-chain aminotransferase** primarily in the muscle. * **Maple Syrup Urine Disease (MSUD):** Caused by a deficiency in the **Branched-chain α-keto acid dehydrogenase** complex. * **Fischer Ratio:** Normal is ~3:1; in hepatic failure, it drops below 1:1.

Q: Succinyl CoA is formed by the metabolism of all the following amino acids except?

Proline. ### Explanation The conversion of amino acids into TCA cycle intermediates is a high-yield topic in NEET-PG. Amino acids that enter the TCA cycle as **Succinyl CoA** are primarily the **VOMIT** group: **V**aline, **O**dd-chain fatty acids (non-amino acid), **M**ethionine, **I**soleucine, and **T**hreonine. **1. Why Proline is the Correct Answer:** Proline is a glucogenic amino acid that is metabolized into **Glutamate**. Glutamate is then converted into **$\alpha$-Ketoglutarate** via oxidative deamination (by glutamate dehydrogenase). Therefore, Proline enters the TCA cycle at the $\alpha$-Ketoglutarate level, not Succinyl CoA. **2. Analysis of Incorrect Options:** * **Isoleucine:** This is both glucogenic and ketogenic. Its carbon skeleton is cleaved to form Acetyl CoA and **Propionyl CoA**. The latter is converted to Succinyl CoA. * **Methionine:** This sulfur-containing amino acid is converted to S-adenosylmethionine (SAM) and eventually to homocysteine. Homocysteine is converted to $\alpha$-ketobutyrate, which enters the pathway to become **Succinyl CoA**. * **Valine:** This branched-chain amino acid (BCAA) undergoes transamination and oxidative decarboxylation to eventually form **Propionyl CoA**, which is then converted to Succinyl CoA. **Clinical Pearls & High-Yield Facts:** * **VOMIT Pathway:** Remember the mnemonic **VOMIT** (Valine, Odd-chain fatty acids, Methionine, Isoleucine, Threonine) for precursors of Propionyl CoA $\rightarrow$ Methylmalonyl CoA $\rightarrow$ **Succinyl CoA**. * **Vitamin B12 Connection:** The conversion of Methylmalonyl CoA to Succinyl CoA requires **Vitamin B12** (cobalamin). Deficiency leads to Methylmalonic aciduria. * **Biotin Connection:** The conversion of Propionyl CoA to Methylmalonyl CoA requires **Biotin** (Vitamin B7).

Amino Acid Metabolism Indian Medical PG Practice Questions and MCQs

Question 1: A child presents with hypopigmented hair and mental retardation, and their urine has a mousy odor. Which enzyme deficiency is responsible?

A. Cystathionine synthase
B. Tyrosine hydroxylase
C. Phenylalanine hydroxylase (Correct Answer)
D. Tyrosine transaminase

Explanation: ### Explanation The clinical presentation of **mental retardation**, **hypopigmented hair**, and a characteristic **mousy (musty) odor** of the urine is a classic description of **Phenylketonuria (PKU)**. **1. Why Phenylalanine Hydroxylase is correct:** PKU is most commonly caused by a deficiency of the enzyme **Phenylalanine Hydroxylase (PAH)**, which converts Phenylalanine to Tyrosine. * **Mousy Odor:** Due to the enzyme block, phenylalanine accumulates and is diverted into alternative pathways, forming phenylketones (like **phenylacetate**), which are excreted in the urine. * **Hypopigmentation:** Tyrosine is a precursor for melanin. Reduced tyrosine levels lead to decreased melanin production, resulting in fair skin and blonde/hypopigmented hair. * **Mental Retardation:** High levels of phenylalanine are neurotoxic and interfere with amino acid transport across the blood-brain barrier. **2. Analysis of Incorrect Options:** * **Cystathionine synthase:** Deficiency causes **Homocystinuria**, characterized by ectopia lentis (downward dislocation), marfanoid habitus, and thromboembolism. * **Tyrosine hydroxylase:** This enzyme converts Tyrosine to L-DOPA. Deficiency leads to infantile parkinsonism and dystonia, but not the classic mousy odor of PKU. * **Tyrosine transaminase:** Deficiency causes **Tyrosinemia Type II** (Richner-Hanhart syndrome), which presents with palmoplantar hyperkeratosis and corneal ulcers. **3. NEET-PG High-Yield Pearls:** * **Inheritance:** Autosomal Recessive. * **Cofactor:** PAH requires **Tetrahydrobiopterin (BH4)**. A deficiency in BH4 or Dihydrobiopterin reductase can cause "Malignant PKU." * **Screening:** Guthrie Test (bacterial inhibition assay) or Tandem Mass Spectrometry. * **Management:** Diet low in phenylalanine and high in tyrosine (Tyrosine becomes an **essential** amino acid in PKU patients). * **Maternal PKU:** If a mother with PKU doesn't maintain a strict diet during pregnancy, the fetus may suffer from microcephaly and congenital heart defects.

Question 2: Carbamoyl phosphate synthase I is involved in which of the following metabolic pathways?

A. Purine synthesis
B. Pyrimidine synthesis
C. Urea cycle (Correct Answer)
D. Uronic acid pathway

Explanation: **Explanation:** **Carbamoyl Phosphate Synthetase I (CPS-I)** is the rate-limiting enzyme of the **Urea Cycle**. It catalyzes the condensation of ammonia ($NH_3$) and bicarbonate ($HCO_3^-$) to form carbamoyl phosphate. This reaction occurs exclusively in the **mitochondria** of hepatocytes and requires **N-acetylglutamate (NAG)** as an essential allosteric activator. **Analysis of Options:** * **A. Purine synthesis:** This pathway utilizes enzymes like PRPP synthetase and GPAT. Nitrogen is derived from glycine, aspartate, and glutamine, but CPS-I is not involved. * **B. Pyrimidine synthesis:** This pathway uses **Carbamoyl Phosphate Synthetase II (CPS-II)**. Unlike CPS-I, CPS-II is located in the **cytosol**, uses **glutamine** as the nitrogen donor, and is not activated by NAG. * **D. Uronic acid pathway:** This is an alternative pathway for glucose metabolism used for the synthesis of glucuronic acid, pentoses, and (in most animals) Vitamin C. It does not involve nitrogen metabolism or CPS enzymes. **High-Yield Clinical Pearls for NEET-PG:** * **CPS-I Deficiency:** The most severe urea cycle disorder, presenting with hyperammonemia, respiratory alkalosis, and neurological symptoms shortly after birth. Unlike OTC deficiency, there is **no orotic aciduria**. * **Mnemonic (CPS-I vs. II):** * **CPS-I:** **M**itochondria, **U**rea cycle (One = m**U**m). * **CPS-II:** **C**ytosol, **P**yrimidine synthesis (Two = **C**y**P**). * **N-acetylglutamate (NAG):** Produced from glutamate and acetyl-CoA; its synthesis is stimulated by Arginine. Without NAG, the Urea cycle cannot proceed.

Question 3: Blue diaper syndrome is associated with which of the following conditions?

A. Tryptophan malabsorption (Correct Answer)
B. Tryptophan hyperabsorption
C. Tyrosine malabsorption
D. Tyrosine hyperabsorption

Explanation: **Explanation:** **Blue Diaper Syndrome** (Drummond’s Syndrome) is a rare, autosomal recessive metabolic disorder characterized by the **isolated malabsorption of Tryptophan** from the intestinal tract. **1. Why Option A is Correct:** In this condition, there is a defect in the transport system responsible for absorbing the amino acid Tryptophan. When Tryptophan remains unabsorbed in the gut, intestinal bacteria metabolize it into **Indole**. This indole is absorbed into the portal circulation and converted by the liver into **Indican** (Indoxyl sulfate). When Indican is excreted in the urine and exposed to air, it undergoes oxidation to form **Indigo Blue**, a water-insoluble pigment that stains the infant's diaper blue. **2. Why Other Options are Incorrect:** * **Option B:** Hyperabsorption of Tryptophan does not occur in this pathology; the issue is a transport deficiency leading to bacterial putrefaction. * **Options C & D:** Tyrosine metabolism defects are associated with conditions like Alkaptonuria (Black urine) or Tyrosinemia, but they do not produce the characteristic blue pigment associated with indole derivatives. **Clinical Pearls for NEET-PG:** * **Clinical Presentation:** Infants present with digestive disturbances, irritability, and visual defects (e.g., cataracts, microphthalmos). * **Hypercalcemia:** Blue Diaper Syndrome is frequently associated with **familial hypercalcemia** and nephrocalcinosis, though the exact mechanism linking tryptophan transport to calcium levels remains unclear. * **Differential Diagnosis:** Do not confuse this with **Hartnup Disease**, which also involves Tryptophan malabsorption but affects other neutral amino acids and presents with pellagra-like skin rashes and ataxia.

Question 4: What is the difference in molecular weight between Phenylalanine and Tyrosine?

A. 17
B. 16 (Correct Answer)
C. 64
D. 32

Explanation: **Explanation:** The difference in molecular weight between Phenylalanine and Tyrosine is **16**, which corresponds to the atomic weight of a single **Oxygen (O)** atom. **1. Why the Correct Answer is Right:** The structural relationship between these two aromatic amino acids is defined by a single hydroxylation reaction. **Phenylalanine** ($C_9H_{11}NO_2$) is converted into **Tyrosine** ($C_9H_{11}NO_3$) by the enzyme **Phenylalanine Hydroxylase (PAH)**. This reaction adds a hydroxyl group (-OH) to the para-position of the phenyl ring. Since Tyrosine is simply "hydroxylated phenylalanine," the net addition is one oxygen atom ($16 \text{ Da}$). While a hydrogen is replaced by -OH, the net gain in mass is $16$ ($17 \text{ for OH} - 1 \text{ for the displaced H}$). **2. Why Other Options are Wrong:** * **Option A (17):** This represents the weight of a hydroxyl group (-OH) alone, without accounting for the displacement of the hydrogen atom from the benzene ring. * **Option C (64) & D (32):** These values do not correspond to any standard functional group differences in basic amino acid metabolism and are distractors. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Essential vs. Non-essential:** Phenylalanine is an **essential** amino acid, while Tyrosine is **semi-essential** (it becomes essential if Phenylalanine is deficient or if PAH is defective). * **Phenylketonuria (PKU):** A deficiency in **Phenylalanine Hydroxylase** (or its cofactor **Tetrahydrobiopterin, $BH_4$**) leads to PKU. In these patients, Tyrosine becomes a strictly essential amino acid. * **Metabolic Fate:** Both are **glucogenic and ketogenic**. They are precursors to Catecholamines (Dopamine, Epinephrine, Norepinephrine), Thyroxine ($T_4$), and Melanin.

Question 5: Which of the following is an optically inactive amino acid?

A. Threonine
B. Tyrosine
C. Glycine (Correct Answer)
D. Serine

Explanation: ### Explanation **Correct Option: C (Glycine)** The optical activity of an amino acid depends on the presence of a **chiral center** (asymmetric carbon atom). A carbon is considered chiral when it is bonded to four different chemical groups. * In all standard amino acids, the $\alpha$-carbon is attached to: 1) an amino group ($-NH_2$), 2) a carboxyl group ($-COOH$), 3) a hydrogen atom ($-H$), and 4) a variable side chain ($-R$ group). * **Glycine** is the simplest amino acid. Its side chain ($-R$ group) is a **hydrogen atom**. Consequently, the $\alpha$-carbon is bonded to two identical hydrogen atoms, making it **achiral** (symmetric). Therefore, Glycine is the only proteinogenic amino acid that is **optically inactive** and does not exist in D- or L- isomeric forms. **Why Other Options are Incorrect:** * **A. Threonine:** Contains two chiral centers (the $\alpha$-carbon and the $\beta$-carbon), making it optically active. * **B. Tyrosine:** An aromatic amino acid with a complex side chain, possessing a chiral $\alpha$-carbon. * **D. Serine:** Contains a hydroxymethyl side chain; its $\alpha$-carbon is attached to four different groups, making it optically active. **High-Yield NEET-PG Clinical Pearls:** 1. **Isoleucine and Threonine:** These are the only two amino acids that possess **two chiral centers**. 2. **L-Configuration:** All amino acids found in human proteins are of the **L-configuration**. 3. **Glycine Functions:** It is essential for the synthesis of **Heme, Purines, Creatine, and Glutathione**. 4. **Inhibitory Neurotransmitter:** Glycine acts as a major inhibitory neurotransmitter in the **spinal cord**. 5. **Proline:** Often called an "imino acid," it contains a secondary amino group and causes "kinks" in alpha-helices.

Question 6: Type I Tyrosinemia is caused by a deficiency in which enzyme?

A. Tyrosine transaminase
B. Fumarylacetoacetate hydrolase (Correct Answer)
C. 4-Hydroxyphenylpyruvate hydroxylase
D. Maleylacetoacetate isomerase

Explanation: ### Explanation **Correct Option: B. Fumarylacetoacetate hydrolase** Type I Tyrosinemia (also known as Tyrosinosis or Hepatorenal Tyrosinemia) is the most severe disorder of tyrosine metabolism. It is caused by a deficiency of **Fumarylacetoacetate hydrolase (FAH)**, the final enzyme in the tyrosine catabolic pathway. This deficiency leads to the accumulation of fumarylacetoacetate, which is diverted into the formation of **succinylacetone**. Succinylacetone is a potent toxin that causes liver failure, renal tubular dysfunction (Fanconi syndrome), and inhibits heme synthesis. **Analysis of Incorrect Options:** * **A. Tyrosine transaminase:** Deficiency causes **Type II Tyrosinemia** (Richner-Hanhart syndrome), characterized by painful corneal erosions and hyperkeratotic plaques on the palms and soles. * **C. 4-Hydroxyphenylpyruvate hydroxylase:** Deficiency leads to **Type III Tyrosinemia**, a very rare condition presenting with neurological symptoms and intellectual disability, but without the liver/kidney involvement seen in Type I. * **D. Maleylacetoacetate isomerase:** Deficiency of this enzyme is theoretically possible but clinically rare; it precedes the FAH step in the catabolic pathway. **High-Yield Clinical Pearls for NEET-PG:** * **Pathognomonic Marker:** Presence of **succinylacetone** in urine is diagnostic for Type I Tyrosinemia. * **Clinical Presentation:** "Cabbage-like" odor, acute hepatic failure, and increased risk of **Hepatocellular Carcinoma (HCC)**. * **Treatment:** **Nitisinone (NTBC)** is the drug of choice. It inhibits 4-hydroxyphenylpyruvate dioxygenase, preventing the formation of toxic metabolites. * **Diet:** Restriction of Phenylalanine and Tyrosine is mandatory.

Question 7: Which of the following amino acids is NOT glucogenic?

A. Arginine
B. Histidine
C. Glycine
D. Lysine (Correct Answer)

Explanation: **Explanation:** Amino acids are classified based on their metabolic end-products into three categories: **Glucogenic** (converted into glucose precursors like pyruvate or TCA cycle intermediates), **Ketogenic** (converted into acetyl-CoA or acetoacetate), or **Both**. **Why Lysine is the Correct Answer:** Lysine, along with Leucine, belongs to the category of **purely ketogenic** amino acids. These two are the only amino acids that cannot be converted into glucose because their catabolism yields only acetyl-CoA or acetoacetate. Since the pyruvate dehydrogenase reaction is irreversible, acetyl-CoA cannot be converted back into pyruvate for gluconeogenesis. **Analysis of Incorrect Options:** * **Arginine:** It is a **glucogenic** amino acid. It is converted into $\alpha$-ketoglutarate via the urea cycle and glutamate, which then enters the TCA cycle to form glucose. * **Histidine:** It is a **glucogenic** amino acid. It is deaminated to urocanate and eventually converted to glutamate, entering the TCA cycle as $\alpha$-ketoglutarate. * **Glycine:** It is a **glucogenic** amino acid. It can be converted into serine and subsequently into pyruvate, a primary substrate for gluconeogenesis. **High-Yield NEET-PG Pearls:** * **Purely Ketogenic:** Lysine and Leucine (Mnemonic: The "L"s are purely ketogenic). * **Both Glucogenic & Ketogenic:** Phenylalanine, Tyrosine, Tryptophan, Isoleucine, and Threonine (Mnemonic: **PITTT**). * **Purely Glucogenic:** All other 13 amino acids. * **Clinical Correlation:** In states of starvation or uncontrolled diabetes, ketogenic amino acids contribute to the formation of ketone bodies, while glucogenic ones maintain blood glucose levels.

Question 8: Carbamoyl phosphate intermediates the synthesis of which of the following?

A. Urea
B. Urea and Pyrimidine (Correct Answer)
C. Uric acid
D. Ketone body

Explanation: **Explanation:** Carbamoyl phosphate is a critical metabolic intermediate that serves as a precursor in two distinct biochemical pathways: the **Urea Cycle** and **Pyrimidine Synthesis**. 1. **Urea Synthesis (Mitochondria):** In the first step of the urea cycle, ammonia and bicarbonate are condensed to form **Carbamoyl Phosphate** by the enzyme **Carbamoyl Phosphate Synthetase I (CPS-I)**. This occurs in the liver mitochondria and is the rate-limiting step for nitrogen excretion. 2. **Pyrimidine Synthesis (Cytosol):** In the de novo synthesis of pyrimidines (leading to UTP, CTP, and TTP), glutamine and bicarbonate form **Carbamoyl Phosphate** via the enzyme **Carbamoyl Phosphate Synthetase II (CPS-II)**. This occurs in the cytosol of most nucleated cells. **Analysis of Incorrect Options:** * **C. Uric acid:** This is the end product of **Purine** catabolism (Adenine and Guanine), not pyrimidine synthesis. * **D. Ketone bodies:** These are synthesized from **Acetyl-CoA** during periods of starvation or untreated diabetes; carbamoyl phosphate is not involved. **High-Yield Clinical Pearls for NEET-PG:** * **CPS-I vs. CPS-II:** Remember the mnemonic: **"I"** is for **I**nside the mitochondria (Urea cycle); **"II"** is for **II** (two) the cytosol (Pyrimidine synthesis). * **Ornithine Transcarbamylase (OTC) Deficiency:** This is the most common urea cycle disorder. When OTC is deficient, mitochondrial carbamoyl phosphate accumulates and leaks into the cytosol, where it enters the pyrimidine pathway, leading to **Orotic Aciduria**. * **Activator:** CPS-I requires **N-acetylglutamate (NAG)** as an absolute allosteric activator.

Question 9: Branched-chain amino acids are used in which of the following conditions?

A. Multiple Organ Dysfunction Syndrome (MODS)
B. Systemic Inflammatory Response Syndrome (SIRS)
C. Sepsis
D. Isolated hepatic failure (Correct Answer)

Explanation: **Explanation:** The correct answer is **Isolated hepatic failure**. **Underlying Concept:** In hepatic failure, the liver’s ability to metabolize aromatic amino acids (AAA: Phenylalanine, Tyrosine, Tryptophan) is severely impaired, leading to elevated plasma levels. Conversely, levels of **Branched-Chain Amino Acids (BCAA: Leucine, Isoleucine, Valine)** decrease because they are primarily metabolized in the skeletal muscle, which becomes hypermetabolic to compensate for the liver's energy deficit. The **Fischer Ratio** (BCAA to AAA ratio) drops significantly. High AAA levels compete with BCAA for transport across the blood-brain barrier via the LAT1 transporter. Excess AAA leads to the production of "false neurotransmitters" (like octopamine), contributing to **Hepatic Encephalopathy**. Supplementing with BCAA-rich formulas helps restore the Fischer ratio, reduces brain uptake of AAA, and provides an alternative energy source for muscles. **Why other options are incorrect:** * **Sepsis, SIRS, and MODS:** These are systemic hypermetabolic states characterized by massive protein catabolism and cytokine storms. While BCAA metabolism is altered, the primary nutritional goal is meeting high caloric/protein demands rather than correcting a specific amino acid imbalance. Clinical trials have not shown a definitive survival benefit for BCAA-specific formulas in these conditions compared to standard high-protein enteral nutrition. **High-Yield Clinical Pearls for NEET-PG:** * **BCAA mnemonic:** **LIV** (Leucine, Isoleucine, Valine). * **Metabolism:** Unlike most amino acids, BCAAs bypass the liver and are metabolized by **Branched-chain aminotransferase** primarily in the muscle. * **Maple Syrup Urine Disease (MSUD):** Caused by a deficiency in the **Branched-chain α-keto acid dehydrogenase** complex. * **Fischer Ratio:** Normal is ~3:1; in hepatic failure, it drops below 1:1.

Question 10: Succinyl CoA is formed by the metabolism of all the following amino acids except?

A. Proline (Correct Answer)
B. Isoleucine
C. Methionine
D. Valine

Explanation: ### Explanation The conversion of amino acids into TCA cycle intermediates is a high-yield topic in NEET-PG. Amino acids that enter the TCA cycle as **Succinyl CoA** are primarily the **VOMIT** group: **V**aline, **O**dd-chain fatty acids (non-amino acid), **M**ethionine, **I**soleucine, and **T**hreonine. **1. Why Proline is the Correct Answer:** Proline is a glucogenic amino acid that is metabolized into **Glutamate**. Glutamate is then converted into **$\alpha$-Ketoglutarate** via oxidative deamination (by glutamate dehydrogenase). Therefore, Proline enters the TCA cycle at the $\alpha$-Ketoglutarate level, not Succinyl CoA. **2. Analysis of Incorrect Options:** * **Isoleucine:** This is both glucogenic and ketogenic. Its carbon skeleton is cleaved to form Acetyl CoA and **Propionyl CoA**. The latter is converted to Succinyl CoA. * **Methionine:** This sulfur-containing amino acid is converted to S-adenosylmethionine (SAM) and eventually to homocysteine. Homocysteine is converted to $\alpha$-ketobutyrate, which enters the pathway to become **Succinyl CoA**. * **Valine:** This branched-chain amino acid (BCAA) undergoes transamination and oxidative decarboxylation to eventually form **Propionyl CoA**, which is then converted to Succinyl CoA. **Clinical Pearls & High-Yield Facts:** * **VOMIT Pathway:** Remember the mnemonic **VOMIT** (Valine, Odd-chain fatty acids, Methionine, Isoleucine, Threonine) for precursors of Propionyl CoA $\rightarrow$ Methylmalonyl CoA $\rightarrow$ **Succinyl CoA**. * **Vitamin B12 Connection:** The conversion of Methylmalonyl CoA to Succinyl CoA requires **Vitamin B12** (cobalamin). Deficiency leads to Methylmalonic aciduria. * **Biotin Connection:** The conversion of Propionyl CoA to Methylmalonyl CoA requires **Biotin** (Vitamin B7).

Practice by Chapter

Protein Digestion and Absorption

Practice Questions

Transamination and Deamination

Practice Questions

Urea Cycle

Practice Questions

Disorders of Urea Cycle

Practice Questions

Metabolism of Individual Amino Acids

Practice Questions

Inborn Errors of Amino Acid Metabolism

Practice Questions

Phenylketonuria and Alkaptonuria

Practice Questions

Homocystinuria and Methionine Metabolism

Practice Questions

Synthesis of Biologically Important Compounds from Amino Acids

Practice Questions

Nitrogen Balance

Practice Questions

Ammonia Metabolism and Toxicity

Practice Questions

One-Carbon Transfer Reactions

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free